Cargando…
Cotrimoxazole as a Preventative Intervention for Pneumocystis Pneumonia in Pemphigus Patients Treated with Rituximab: A Retrospective Study
INTRODUCTION: Pneumocystis jirovecii pneumonia (PJP) is a severe, life-threatening complication in patients treated with rituximab. However, there is no consensus on the primary prophylaxis for it in rituximab-treated pemphigus patients. Therefore, we sought to investigate the prophylactic efficacy...
Autores principales: | Hsu, Hao-Chen, Huang, Po-Wei, Cho, Yung-Tsu, Chu, Chia-Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10307752/ https://www.ncbi.nlm.nih.gov/pubmed/37322166 http://dx.doi.org/10.1007/s13555-023-00953-9 |
Ejemplares similares
-
Cotrimoxazole/pentamidine: Lack of efficacy in Pneumocystis jirovecii pneumonia: case report
Publicado: (2021) -
Pneumocystis jirovecii pneumonia in HIV-uninfected, rituximab treated non-Hodgkin lymphoma patients
por: Wei, Kai-Che, et al.
Publicado: (2018) -
Refractory pemphigus vulgaris treated with rituximab and mycophenolate
mofetil
por: Biot, Stephanie Del Rio Navarrete, et al.
Publicado: (2014) -
Rituximab in the Treatment of Pemphigus Vulgaris
por: Zakka, Labib R., et al.
Publicado: (2012) -
Real world evidence: Patients with refractory pemphigus treated with Rituximab
por: Perifani, Vagiani, et al.
Publicado: (2021)